Both in Pharmaceuticals
Trevi Therapeutics vs Harmony Biosciences Holdings
Over the past year TRVI returned +28.8% and HRMY returned +12.0%; their daily moves had a correlation of 0.21.
TRVI +28.8% HRMY +12.0%Growth of $1, one year, split-adjusted
| Metric | TRVI | HRMY |
|---|---|---|
| Price | $13.99 | $34.42 |
| Market cap | $1.99B | $2.00B |
| Today | +0.90% | −7.04% |
| 1 month | +6.1% | −12.6% |
| 6 months | −1.9% | +5.0% |
| Year to date | +11.7% | −8.0% |
| 1 year | +30.7% | +17.3% |
| Revenue growth (YoY) | — | +30.3% |
| Gross margin | — | 75.8% |
| Net margin | — | 28.9% |
| P/E (TTM) | — | 11.1× |
| Price / sales | — | 2.1× |
| Net cash | $318.9M | $513.8M |
| Dividend yield | — | — |
| Volatility (60d) | 39.4% | 35.9% |
| Short % of float | 14.4% | 11.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).